KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Enterprise Value (2016 - 2025)

Exact Sciences has reported Enterprise Value over the past 16 years, most recently at -$964.7 million for Q4 2025.

  • Quarterly Enterprise Value rose 7.06% to -$964.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$964.7 million through Dec 2025, up 7.06% year-over-year, with the annual reading at -$964.7 million for FY2025, 7.06% up from the prior year.
  • Enterprise Value was -$964.7 million for Q4 2025 at Exact Sciences, up from -$1.0 billion in the prior quarter.
  • Over five years, Enterprise Value peaked at -$213.0 million in Q2 2025 and troughed at -$1.4 billion in Q1 2021.
  • The 5-year median for Enterprise Value is -$801.6 million (2022), against an average of -$869.6 million.
  • Year-over-year, Enterprise Value crashed 39.04% in 2024 and then soared 77.5% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$1.0 billion in 2021, then surged by 38.66% to -$632.1 million in 2022, then dropped by 23.03% to -$777.6 million in 2023, then tumbled by 33.48% to -$1.0 billion in 2024, then increased by 7.06% to -$964.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Enterprise Value are -$964.7 million (Q4 2025), -$1.0 billion (Q3 2025), and -$213.0 million (Q2 2025).